Bioverativ

http://dbpedia.org/resource/Bioverativ an entity of type: Thing

Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company traded on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition on March 8, 2018. rdf:langString
rdf:langString Bioverativ
rdf:langString Bioverativ Inc.
rdf:langString Bioverativ Inc.
xsd:integer 51795199
xsd:integer 1107752903
xsd:integer 2016
rdf:langString
rdf:langString
rdf:langString John G. Cox
xsd:integer 400
rdf:langString Alprolix, Eloctate
rdf:langString Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company traded on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition on March 8, 2018.
xsd:nonNegativeInteger 6916
xsd:gYear 2016
xsd:nonNegativeInteger 400

data from the linked data cloud